José Meca-Lallana
University Hospital of Lausanne(CH)Hospital Universitario Virgen de la Arrixaca(ES)Universidad Católica de Murcia(ES)University of Lausanne(CH)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, SARS-CoV-2 and COVID-19 Research, Rheumatoid Arthritis Research and Therapies
Most-Cited Works
- → Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial(2021)179 cited
- → Neuromyelitis optica spectrum disorders(2016)151 cited
- → Neurotrophic Bone Marrow Cellular Nests Prevent Spinal Motoneuron Degeneration in Amyotrophic Lateral Sclerosis Patients: A Pilot Safety Study(2012)120 cited
- → Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial(2022)106 cited
- → Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial(2021)79 cited
- → Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS